Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension

Abstract

Longstanding and therapy-resistant hypertension may cause cerebral, renal, cardiac and retinal end-organ damage (EOD). Retinal hypertensive abnormalities are correlated with an increased risk of cardiovascular (CV) disease in general but are not included in CV risk assessment tools. Research into prevalence and determinants of retinal organ damage, such as hypertensive retinopathy (HR), is scarce. We evaluated the prevalence of HR and the association with other signs of EOD in patients with hypertension. A retrospective observational study was performed in all hypertensive patients referred by a general practitioner to the hypertension clinic at the Diakonessenhuis, Utrecht and Zeist, the Netherlands between 2011 and 2013. A screening of risk factors, albuminuria, left-ventricular hypertrophy (LVH) and retinal fundoscopy was performed. In all, 44% (123/280) of patients referred to the clinic were diagnosed with HR, while 15 and 11% were diagnosed with LVH and microalbuminuria, respectively. Patients with isolated HR consisted of 31% of all patients. When HR was added as a form of EOD, the percentage of patients with a treatment indication increased from 3 to 14%. Patients who were already on treatment goal exhibited a high prevalence of HR (28%), warranting treatment intensification. HR is prevalent in a third of hypertensive patients referred to our clinic, and isolated HR accounts for the majority of (end-) organ damages. Fundoscopy in the evaluation of hypertension might improve the indication for therapy. Furthermore, diagnosing HR could be helpful in selecting patients with hypertension on treatment goal in need of more aggressive treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–838.

    Article  CAS  Google Scholar 

  2. Muiesan ML, Salvetti M, Rizzoni D, Paini A, gabiti-Rosei C, Aggiusti C et al. Resistant hypertension and target organ damage. Hypertens Res 2013; 36: 485–491.

    Article  Google Scholar 

  3. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357.

    Article  CAS  Google Scholar 

  4. James PA, Oparil S, Carter BL, Cushman WC, nison-Himmelfarb C, Handler J et al. evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507–520.

    Article  CAS  Google Scholar 

  5. Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN, Hubbard LD et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. Stroke 2006; 37: 82–86.

    Article  Google Scholar 

  6. Mimoun L, Massin P, Steg G . Retinal microvascularisation abnormalities and cardiovascular risk. Arch Cardiovasc Dis 2009; 102: 449–456.

    Article  Google Scholar 

  7. Longstreth W Jr . Larsen EK, Klein R, Wong TY, Sharrett AR, Lefkowitz D et al. Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the Cardiovascular Health Study. Am J Epidemiol 2007; 165: 78–84.

    Article  Google Scholar 

  8. Ong YT, Wong TY, Klein R, Klein BE, Mitchell P, Sharrett AR et al. Hypertensive retinopathy and risk of stroke. Hypertension 2013; 62: 706–711.

    Article  CAS  Google Scholar 

  9. Sairenchi T, Iso H, Yamagishi K, Irie F, Okubo Y, Gunji J et al. Mild retinopathy is a risk factor for cardiovascular mortality in Japanese with and without hypertension: the Ibaraki Prefectural Health Study. Circulation 2011; 124: 2502–2511.

    Article  Google Scholar 

  10. Suri MF, Qureshi AI . Hypertensive retinopathy and risk of cardiovascular diseases in a national cohort. J Vasc Interv Neurol 2008; 1: 75–78.

    PubMed  PubMed Central  Google Scholar 

  11. Duncan BB, Wong TY, Tyroler HA, Davis CE, Fuchs FD . Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 2002; 86: 1002–1006.

    Article  CAS  Google Scholar 

  12. Schouten EG, Vandenbroucke JP, van d H-W, van der Heide RM . Retinopathy as an independent indicator of all-causes mortality. Int J Epidemiol 1986; 15: 234–236.

    Article  CAS  Google Scholar 

  13. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De BG et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.

    Article  CAS  Google Scholar 

  14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1–266.

    Google Scholar 

  15. Use of glycated haemoglobin (HbA1c in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation [webpage on the Internet]. Geneva: World Health Organization, 2011. Available from http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en/Accessed.

  16. Alberti KG, Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553.

    Article  CAS  Google Scholar 

  17. Keith NM, Wagener HP, Barker NW . Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974; 268: 336–345.

    Article  CAS  Google Scholar 

  18. Toto RD . Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens (Greenwich) 2004; 6: 2–7.

    Article  CAS  Google Scholar 

  19. Sokolow M, Lyon TP . The ventricular complex in right ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 38: 273–294.

    Article  CAS  Google Scholar 

  20. Figueiredo Neto JA, Palacio GL, Santos AN, Chaves PS, Gomes GV, Cabral TS . Direct ophthalmoscopy versus detection of hypertensive retinopathy: a comparative study. Arq Bras Cardiol 2010; 95: 215–221.

    Article  Google Scholar 

  21. Helvaci MR, Ozcura F, Kaya H, Yalcin A . Funduscopic examination has limited benefit for management of hypertension. Int Heart J 2007; 48: 187–194.

    Article  Google Scholar 

  22. Cuspidi C, Macca G, Salerno M, Michev L, Fusi V, Severgnini B et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J 2001; 2: 702–706.

    CAS  PubMed  Google Scholar 

  23. Erden S, Bicakci E . Hypertensive retinopathy: incidence, risk factors, and comorbidities. Clin Exp Hypertens 2012; 34: 397–401.

    Article  Google Scholar 

  24. Triantafyllou A, Anyfanti P, Zabulis X, Gavriilaki E, Karamaounas P, Gkaliagkousi E et al. Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients. J Am Soc Hypertens 2014; 8: 542–549.

    Article  CAS  Google Scholar 

  25. Gudmundsdottir H, Taarnhoj NC, Strand AH, Kjeldsen SE, Hoieggen A, Os I . Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men. J Hum Hypertens 2010; 24: 505–513.

    Article  CAS  Google Scholar 

  26. Cugati S, Cikamatana L, Wang JJ, Kifley A, Liew G, Mitchell P . Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study. Eye (Lond) 2006; 20: 1239–1245.

    Article  CAS  Google Scholar 

  27. Biesenbach G, Zazgornik J . High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol 1994; 41: 211–218.

    CAS  PubMed  Google Scholar 

  28. Wang S, Xu L, Jonas JB, Wang YS, Wang YX, You QS et al. Five-year incidence of retinal microvascular abnormalities and associations with arterial hypertension: the Beijing Eye Study 2001/2006. Ophthalmology 2012; 119: 2592–2599.

    Article  Google Scholar 

  29. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K . Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens 1995; 13: 155–160.

    Article  CAS  Google Scholar 

  30. Karaca M, Coban E, Ozdem S, Unal M, Salim O, Yucel O . The association between endothelial dysfunction and hypertensive retinopathy in essential hypertension. Med Sci Monit 2014; 20: 78–82.

    Article  CAS  Google Scholar 

  31. Coban E, Nizam I, Topal C, Akar Y . The association of low-grade systemic inflammation with hypertensive retinopathy. Clin Exp Hypertens 2010; 32: 528–531.

    Article  CAS  Google Scholar 

  32. Coban E, Alkan E, Altuntas S, Akar Y . Serum ferritin levels correlate with hypertensive retinopathy. Med Sci Monit 2010; 16: CR92–CR95.

    CAS  PubMed  Google Scholar 

  33. Foguet Q, Rodriguez A, Saez M, Ubieto A, Beltran M, Barcelo MA et al. Usefulness of optic fundus examination with retinography in initial evaluation of hypertensive patients. Am J Hypertens 2008; 21: 400–405.

    Article  Google Scholar 

  34. Joshi V, Agurto C, VanNess R, Nemeth S, Soliz P, Barriga S . Comprehensive automatic assessment of retinal vascular abnormalities for computer-assisted retinopathy grading. Conf Proc IEEE Eng Med Biol Soc 2014; 2014: 6320–6323.

    PubMed  Google Scholar 

  35. Schuster AK, Fischer JE, Vossmerbaeumer C, Vossmerbaeumer U . Optical coherence tomography-based retinal vessel analysis for the evaluation of hypertensive vasculopathy. Acta Ophthalmol 2015; 93: e148–e153.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A M van Sijl.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kolman, S., van Sijl, A., van der Sluijs, F. et al. Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension. J Hum Hypertens 31, 121–125 (2017). https://doi.org/10.1038/jhh.2016.49

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2016.49

This article is cited by

Search

Quick links